ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Vitamin D Deficiency Linked to Neurological Diseases; Also Raises Risk of Asthma Attacks, and More

7 Best Foods You Can Eat

Study: Doubling saturated fat in the diet does not increase saturated fat in blood

The Gut Microbiome and the Brain

Fight Inflammation and Promote Cognitive Health with High-OPC Grape Seed

CoQ10 supplementation reduces statin-related muscle pain in randomized trial

Controlling obesity with potato extract

Plant used in traditional Chinese medicine may treat metabolic diseases and obesity

Natural Gut Viruses Join Bacterial “Cousins” in Maintaining Health and Fighting Infections

Proton pump inhibitors decrease diversity in gut microbiome, increase risk for complications

 
Print Page
Email Article

‘Lipkin’ ME/CFS Virus Report Embargo to End at 12:01 AM, Sep 18

  [ 13 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 10, 2012


Sep 16 Update: A post on XMRV Global Action's Facebook site has reported a notice from the CFIDS Assoc. indicating that the findings of the study of virus involvement in ME/CFS patient samples, led by Columbia University 'virus hunter' Ian Lipkin, MD, will be released in the wee hours, at 12:01 AM Eastern Time Tuesday Sep 18 (9:01 PM Sep 17, Pacific Time). It will be published by the open access journal mBio (http://mBio.asm.org).

Also preceding the planned Tuesday morning Columbia press conference described below, Dr. Lipkin will discuss the study results in a special episode of the netcast that colleague Dr. Vicent Racaniello hosts - "This Week in Virology" - to begin at 12:01 AM Eastern Time (http://www.twiv.tv).

_____________________________________

Apparently the press event that Columbia announced last week...

...will still be streamed live starting at 10:30 AM Eastern Time (7:30 AM Pacific) on Tuesday, September 18, according to Columbia's Center for Infection and Immunity (CII).

The live press conference will be found on the CII website (www.cii.columbia.edu).

See the full announcement of this press event below.

__________________________

CII Press Conference September 18th, 2012
10:30 AM (EDT) and 7:30 AM Pacific Time


“Multicenter Study on Chronic Fatigue Syndrome/Myalgic Encephalomyelitis”

The causes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) have long eluded scientists. In 2009/2010, two high-profile papers linked the syndrome to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus) and murine retrovirus-like sequences (designated pMLV: polytropic MLV). Given that affected patients often have symptoms consistent with a chronic infection, this viral connection was deemed plausible, and the findings were celebrated as a major achievement for a complex disease that afflicts nearly 1 million in the U.S.

However, follow-up investigations by several laboratories were unable to detect XMRV or pMLV in CFS patients.

To definitively resolve this issue, the National Institute of Allergy and Infectious Diseases commissioned a large-scale, multicenter study under the auspices of the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health, in partnership with the Centers for Disease Control and Prevention, the Food and Drug Administration, the NIH’s National Cancer Institute and Warren G. Magnuson Clinical Center, and others (see full list below).

Investigators from the multicenter study on CFS/ME and XMRV/pMLV will discuss their findings and future directions. A live video will be posted below [CII blog page - http://cii.columbia.edu/blog.htm?cid=tM5E7V?].

For attendance at the event, members of the media should RSVP by 9:00 AM on Monday, Sept. 17th to Nsikan Akpan (212-342-9051 | nea2107@columbia.edu) or Stephanie Berger, Mailman School of Public Health (212-305-4372 | sb2247@columbia.edu).

WHEN: Tuesday, September 18, 2012
            Press Conference begins at 10:30 AM (EDT)

WHO: W. Ian Lipkin, MD (Moderator)
Center for Infection and Immunity (CII), Mailman School of Public Health, Columbia University
• Principal Investigator and Director of Center for Infection and Immunity
• John Snow Professor of Epidemiology
• Professor of Neurology and Pathology
 
Harvey Alter, MD
National Institutes of Health, Department of Transfusion Medicine
• Distinguished NIH Investigator
• Chief, Clinical Studies
• Associate Director of Research
 
Mady Hornig, MD
Center for Infection and Immunity, Mailman School of Public Health, Columbia University
• Director of Translational Research at CII
• Associate Professor of Epidemiology

Judy Mikovits, PhD
Mikovits Consulting
 
Francis Ruscetti, PhD
National Cancer Institute, Frederick National Laboratory for Cancer Research
• Head, Leukocyte Biology Section
• Senior Investigator

Collaborating Research Groups:

Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD.

Mikovits Consulting, Oxnard, CA.

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA.

Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD.

Tissue Safety Laboratory, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD.

Nova Southeastern University, Fort Lauderdale FL.

Miami Veterans Affairs Medical Center, Miami, FL.

Brigham and Women’s Hospital, Boston, MA.

Infectious Disease Clinic, Stanford University, Palo Alto, CA.

Fatigue Consultation Clinic, Salt Lake City, UT.

Levine Clinic, New York, NY.

Simmaron Research Institute, Incline Village, NV.

Department of Biostatistics, Columbia University, New York, NY.

Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY.

Center for Infection and Immunity, Columbia University, New York, NY.

Department of Molecular Biology and Microbiology, Tufts University, Boston, MA.



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Nutritional Supplement Orders

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health

Natural Remedies

Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?
Protecting Our Eyes Against Time-Induced Damage Protecting Our Eyes Against Time-Induced Damage
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
Sunshine Vitamin Has D-lightful Health Benefits Sunshine Vitamin Has D-lightful Health Benefits
Rejuvenating the Brain - How PQQ Helps Power Up Mental Processing Rejuvenating the Brain - How PQQ Helps Power Up Mental Processing

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS Diagnosis
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE  |  PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing